Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2023-09-15
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor Imagery in Aphantasia
NCT06140940
Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
NCT07256704
Standardization of Spatial Neglect Assessment Tests
NCT07145970
Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits
NCT05501405
Multisensory Integration and Cognitive Awareness in Post-Stroke Unilateral Spatial Neglect
NCT06690125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute stroke group
Patients receive treatment 6-12 weeks after stroke.
1hz repetitive transcranial magnetic stimulation
1hz rTMS applied over P3 EEG 10-20 location. Total of 1200 pulses administered. Figure of eight coil used to stimulate, held tangential to the scalp.
Subacute stroke group
Patients receive treatment 16-20 weeks after stroke.
1hz repetitive transcranial magnetic stimulation
1hz rTMS applied over P3 EEG 10-20 location. Total of 1200 pulses administered. Figure of eight coil used to stimulate, held tangential to the scalp.
Chronic stroke group
Patients receive treatment 52+ weeks after stroke.
1hz repetitive transcranial magnetic stimulation
1hz rTMS applied over P3 EEG 10-20 location. Total of 1200 pulses administered. Figure of eight coil used to stimulate, held tangential to the scalp.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1hz repetitive transcranial magnetic stimulation
1hz rTMS applied over P3 EEG 10-20 location. Total of 1200 pulses administered. Figure of eight coil used to stimulate, held tangential to the scalp.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\) Age between 18-80 years old.
* 3\) CBS score of \>8
* 4\) Informed consent provided by patient or proxy.
Exclusion Criteria
* 2\) Electrical device implants or metal objects in the body
* 2\) Patients receiving end-of-life care
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Landspitali University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marianne Elisabeth Klinke
Professor in Nursing and academic chair in neurology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Experimental
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.